What is the role of Brainstem Evoked Response Audiometry (BERA) or Auditory Brainstem Response (ABR) testing in diagnosing hearing loss?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brainstem Evoked Response Audiometry (BERA/ABR) in Diagnosing Hearing Loss

Brainstem Evoked Response Audiometry (ABR) serves as both a screening tool for newborns and a definitive diagnostic test for infants and children who cannot cooperate with behavioral audiometry, providing ear-specific, frequency-specific hearing thresholds that are accurate enough to guide amplification fitting. 1

Primary Clinical Applications

Newborn Hearing Screening

  • Automated ABR is the mandatory screening method for all NICU infants hospitalized >5 days to detect neural hearing loss (auditory neuropathy/dyssynchrony) that otoacoustic emissions (OAEs) would miss 1
  • For well-infant nurseries, either automated ABR or OAEs can be used as the initial screening tool 1
  • Infants who fail automated ABR screening in the NICU should be referred directly to an audiologist for comprehensive diagnostic evaluation, bypassing rescreening 1

Diagnostic Evaluation (Birth to 6 Months)

When permanent hearing loss is suspected, diagnostic ABR must include: 1

  • Frequency-specific ABR using air-conducted tone bursts at multiple frequencies to create an audiogram-like map of hearing thresholds
  • Click-evoked ABR with both condensation and rarefaction stimuli to detect cochlear microphonics and rule out auditory neuropathy/dyssynchrony, particularly in infants with risk factors (hyperbilirubinemia, anoxia) 1
  • Bone-conduction ABR when indicated to differentiate conductive from sensorineural hearing loss 1

Critical caveat: Any infant showing "no response" on tone-burst ABR must be evaluated with click-evoked ABR, as some infants with neural hearing loss have no identifiable risk factors 1

When ABR is the Definitive Test

Infants and Young Children (Birth to ~3-6 Months)

  • Diagnostic ABR is the gold standard when behavioral audiometry cannot be obtained 1, 2
  • The test provides sufficiently accurate frequency-specific thresholds to allow hearing aid fitting without behavioral confirmation 1
  • Natural sleep is adequate for infants up to 3-6 months of age; sedation is typically required for older infants and children 1, 3

Older Children with Special Circumstances

ABR remains necessary for: 1

  • Children with developmental delays, autism, or behavioral problems that preclude accurate behavioral audiometry
  • Any child where behavioral audiometry results are unreliable or inconsistent 1, 2
  • Confirmation of hearing loss in children younger than 3 years—at least one ABR test is recommended as part of complete diagnostic evaluation 1

Test Characteristics and Limitations

Advantages

  • Ear-specific results obtained through insert earphones 1
  • Does not require patient cooperation—responses are neurologic, not behavioral 1
  • Unaffected by anesthesia or sedation 4
  • Can test across multiple frequencies (250 Hz to 8 kHz with appropriate protocols) 1

Critical Limitations

ABR is NOT a true test of hearing because it only assesses auditory pathway structural integrity up to the brainstem—it does not evaluate cortical processing of sound 1

Common pitfalls to avoid: 4, 5

  • High-frequency sensorineural hearing loss may produce abnormal waveforms or absent responses even when lower frequencies are normal
  • The child must remain quiet during testing; motion artifact invalidates results
  • Interpretation is subjective despite objective recording—use evidence-based signal detection criteria and appropriate signal-to-noise ratios 5

Integration with Other Tests

Mandatory Cross-Checks

Never rely on ABR alone. The diagnostic battery must include: 1, 5

  • Otoacoustic emissions (OAEs) to assess cochlear function
  • Tympanometry with 1000-Hz probe tone (for infants <6 months) to rule out middle ear pathology 1
  • Behavioral audiometry as soon as developmentally appropriate—this remains the true standard for hearing evaluation 1

Age-Appropriate Follow-Up Testing

  • 6-36 months: Transition to behavioral audiometry (visual reinforcement or conditioned-play audiometry depending on developmental level); use ABR only if behavioral results are unreliable 1
  • >2.5 years: Play audiometry becomes the preferred method 1
  • >4 years: Conventional audiometry is appropriate 1

Timing and Intervention

Infants with confirmed hearing loss must receive: 1

  • Diagnostic evaluation completed by 3 months of age
  • Hearing aid fitting within 1 month of diagnosis if family chooses amplification 1, 2
  • Early intervention services initiated by 6 months of age 1

For children with risk factors who pass newborn screening: At least one diagnostic audiology assessment (including ABR if behavioral testing is unreliable) should occur by 24-30 months of age, with earlier and more frequent assessment for high-risk conditions like CMV infection or progressive syndromes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Approach and Management of Unilateral Sensorineural Hearing Loss in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

How to perform ABR in young children.

European annals of otorhinolaryngology, head and neck diseases, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.